Editor's Page

Collectively, this issue of JCP presents how market dynamics are changing in relation to oncology practices, what providers are doing to evolve with these changes, and how clinical pathways are advancing these changes to achieve better care for patients.
As another year draws to a close, I look back on the work produced by Journal of Clinical Pathways with pride. But it is still important to keep our focus on what’s next.
New developments within the parameters of clinical pathways and value-based care offer many possibilities, and the current issue of Journal of Clinical Pathways offers a wide scope of where the field stands.
Medicine changes rapidly, but you can always count on Journal of Clinical Pathways for the latest information on value-based care.
For those of us at Journal of Clinical Pathways, September marks our Clinical Pathways Congress, held the weekend of September 8 in Washington, DC. Although the Congress may be our primary focus, it is certainly not the only iron we have in the fire.
Our annual Clinical Pathways Congress (CPC) will be held in Washington, DC, over the second weekend in September, and we hope to see many of our readers there. We have reached an exciting moment in clinical pathways development.
Between the state of cancer care in America, the continued debate over the country’s health care system, and the best treatment practices for older adults, this issue of Journal of Clinical Pathways presents a broad spectrum of important issues in the field of value-based care. 
It is an exciting time to be involved in the development of clinical pathways and value-based care, as these studies—and the research coming out of ASCO—show.
Clinical pathways have served to promote evidence-based medicine and value-based care across the medical continuum. 
Health care delivery is always in flux, but treatment advances have introduced new variables into the health care continuum that were unthinkable even a decade ago.